Mr. Jake Kalpakian reports
37 CAPITAL ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT FINANCING
Further to the news release dated March 17, 2026, 37 Capital Inc. has closed the first tranche of the non-brokered private placement for gross proceeds of $210,000 and issued three million units of the company at the price of seven cents per unit. Each unit consists of one common share of the company and one share purchase warrant, with each warrant exercisable to acquire one common share of the company at a price of 10 cents per share for a period of three years until May 25, 2029, subject to acceleration provision. The company expects to close the remaining balance by the end of the month.
The proceeds from the financing will be used for general working capital purposes.
All securities issued under this private placement are subject to a hold period expiring on Sept. 26, 2026.
Early warning report
Pursuant to the above private placement, Christoopher Kape, through his private company, has acquired three million common shares of 37 Capital at the price of seven cents per unit totalling $210,000. As a result of the acquisition, Mr. Kape now has ownership and control of 3,872,097 common shares, representing approximately 12.65 per cent of the issued and outstanding common shares of 37 Capital as at May 25, 2026, and Mr. Kape has ownership and control of three million warrants, representing approximately 18.45 per cent of the issued and outstanding warrants of 37 Capital as at May 25, 2026.
Mr. Kape may acquire further common shares of, or dispose his holdings of common shares of, 37 Capital through the market, privately or otherwise, as circumstances or market conditions warrant.
A copy of the early warning report from Mr. Kape has been filed with the applicable securities regulators regarding the transaction and is available on SEDAR+. A copy of the early warning report by Mr. Kape and further information may also be obtained by contacting 37 Capital at 604-681-0204 or Mr. Kape at 702-899-9990.
We seek Safe Harbor.
© 2026 Canjex Publishing Ltd. All rights reserved.